"Filling the Gaps: A Novel Crowdfunding Platform for Global Health"

Date
Mar 3, 2015, 6:00 pm7:00 pm
Location
Bowl 2, Robertson Hall
Audience
Students, Faculty, Fellows & Staff - registration required
Event Description

Dinner Seminar

From Kickstarter to Indiegogo, crowdfunding is a multi-billion dollar field which has revolutionized the way that that social media funds innovative and exciting ideas. Derek Fetzer and Ben Tiede PhD ’10, MPP ’11 from Janssen, the pharmaceutical company of Johnson & Johnson, will present about a new crowdfunding platform being launched specifically to fund NGOs working in global health. At the seminar, Derek and Ben will provide an overview of the platform and discuss opportunities for Princeton students to contribute.  

Derek FetzerDirector, Global Public Health, Janssen – Pharmaceutical Companies of Johnson & Johnson

Mr. Fetzer has worked in marketing, market research, and strategy for the last 23 years, working primarily in the pharmaceutical industry.  Originally from Peru, he has worked and lived in the USA, Peru, Mexico, Brazil, Belgium, and Holland.

For the last 10 years, he has led business analytics in the area of infectious diseases, particularly HCV, HIV/AIDS, and tuberculosis.  He has been engaged in the commercial and strategic development of key pharmaceuticals, such as Incivo, Prezista, Intelence, Sirturo, and Edurant.  For the past 2 years, he has been working in the area of global public health by leading crowdfunding platform development and access innovation.

Mr. Fetzer holds an MS in Industrial Engineering (’95) and an MBA (’00), both from Purdue University.  

Ben TiedeDirector, Strategy & Business Transformation, Janssen – Pharmaceutical Companies of Johnson & Johnson

Dr. Benjamin Tiede, PhD ‘10 MPP ‘11 is a Director of Strategy and Business Transformation at Janssen, the pharmaceutical companies of Johnson & Johnson.  In this role, he is responsible for thought leadership on a wide range of innovative topics for the Janssen Worldwide Chairmen. Currently, he is leading a multifunctional initiative preparing for the future of Precision Medicine and is supporting a company-wide effort to better leverage the potential of Real World Evidence. 

Previously, Ben was a Director at Global Health Strategies (GHS), an international communications and advocacy consulting company focused on improving health in developing countries. While at GHS, Ben supported a range of clients, including the Bill & Melinda Gates Foundation, GlaxoSmithKline Vaccines, the ExxonMobil Foundation and others.  His primary areas of focus included Neglected Tropical Diseases (NTDs), HIV and diarrheal disease.  He holds a Ph.D. in Molecular Biology from Princeton University and a Master in Public Policy degree from the Woodrow Wilson School of Public and International Affairs at Princeton University.  

Dinner will be served.

RSVP required. Please email chw@princeton.edu by February 24th.

This event is sponsored by the Woodrow Wilson School's Center for Health and Wellbeing.